Detail Article

Informations générales (source: ClinicalTrials.gov)

Numéro NCT

NCT03963622 En recrutement IDF

Titre

Careful Ventilation in Acute Respiratory Distress Syndrome (CAVIARDS)

Type

Interventional

Pathologie

Syndrome de détresse respiratoire du nouveau-né
Syndrome de détresse respiratoire de l'adulte
Lésion pulmonaire aigüe

Phase

N/A

Promoteur

Unity Health Toronto (Voir sur ClinicalTrials)

Date de début

novembre 2020

Date de fin

mars 2026

Dernière mise à jour

14 novembre 2024

Résumé

This is a multicenter randomized controlled clinical trial with an adaptive design assessing the efficacy of setting the ventilator based on measurements of respiratory mechanics (recruitability and effort) to reduce Day 60 mortality in patients with acute respiratory distress syndrome (ARDS). The CAVIARDS study is also a basket trial; a basket trial design examines a single intervention in multiple disease populations. CAVIARDS consists of an identical 2-arm mechanical ventilation protocol implemented in two different study populations (COVID-19 and non-COVID-19 patients). As per a typical basket trial design, the operational structure of both the COVID-19 substudy (CAVIARDS-19) and non-COVID-19 substudy (CAVIARDS-all) is shared (recruitment, procedures, data collection, analysis, management, etc.).

Détail

Voir le détail Acute respiratory distress syndrome (ARDS) is a major public health problem affecting approximately 10% of patients in the intensive care unit (ICU) and 23% of all patients on a breathing machine (mechanical ventilator). The short-term mortality of patients with ARDS is approximately 40% and better ventilation of these patients has the greatest potential to improve outcomes. The lungs in patients with ARDS are severely inflamed which reduces lung volume and their ability to stretch, making ventilation difficult and dangerous. However, mechanical ventilation is the mainstay of supportive therapy. Although it is life-saving, it can also can generate secondary injury and inflammation, called ventilator-induced lung injury (VILI). The investigators know that inadequate mechanical ventilation worsens outcomes but are uncertain of the optimal way to manage ventilators at the bedside. Furthermore, ARDS is challenging because there is no treatment for the alveolar-capillary leak characterizing this syndrome; aside from treating the underlying cause, the only supportive therapy is mechanical ventilation. This is specially the case for COVID-19 induced ARDS. Despite best practices, over-distension of the lung or inappropriate positive end expiratory pressure (PEEP) is common. Finally, once spontaneous breathing has resumed and is assisted by the ventilator, an additional phenomenon occurs, called patient self-inflicted lung injury. The drive for breathing in many patients is stimulated by lung inflammation, and strong breathing efforts can generate high distending pressures, causing lung (and systemic) inflammation and organ damage. Whether the management of COVID-19 induced ARDS should differ from all other ARDS has been debated at length but has no clear response Recent advances in our understanding of bedside physiology (airway closure, recruitability, lung distension, respiratory drive) can now be applied for an individual titration of mechanical ventilation. Fermer le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AP-HP - Hôpital Europeen Georges Pompidou	Jean-Luc Diehl, MD	En recrutement IDF	Contact (sur clinicalTrials)
CHI DE CRETEIL	Tommaso Maraffi, MD	En recrutement IDF	Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre hospitalier universitaire d'Angers - Angers - France	Francois Beloncle, MD	En recrutement	Contact (sur clinicalTrials)
CH Bretagne Atlantique Vannes-Auray - Vannes - France	Agathe Delbove, MD	En recrutement	Contact (sur clinicalTrials)
CH de Beauvais - Beauvais - France	Jack Richecoeur, MD	En recrutement	Contact (sur clinicalTrials)
CH de Cholet - Cholet - France	Johann Auchabie, MD	En recrutement	Contact (sur clinicalTrials)
CH Victor Dupouy - Argenteuil - France	Gaetan Plantefeve, MD	En recrutement	Contact (sur clinicalTrials)
CHU Amiens-Picardie - Amiens - France	Michel Slama, MD	En recrutement	Contact (sur clinicalTrials)
CHU Bordeaux - Haut Leveque - Bordeaux - France	Benjamin Repusseau, MD	En recrutement	Contact (sur clinicalTrials)
CHU de Poitiers - La Miletrie - Poitiers - France	Remi Coudroy, MD	En recrutement	Contact (sur clinicalTrials)
CHU Grenoble-Alpes - Grenoble - France	Florian Sigaud, MD	En recrutement	Contact (sur clinicalTrials)
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace - Mulhouse - France	Khaldoun Kuteifan, MD	En recrutement	Contact (sur clinicalTrials)
HIA Robert Picque - Villenave-d'Ornon - France	David Tran-Van, MD	En recrutement	Contact (sur clinicalTrials)
Hopital de la Cavale Blanche - CHRU Brest - Brest - France	Gwenael Prat, MD	En recrutement	Contact (sur clinicalTrials)
Hopital de l'Archet 1 - CHU de Nice - Nice - France	Jean Dellamonica, MD	En recrutement	Contact (sur clinicalTrials)
Hopital Roger Salengro - CHU Lille - Lille - France	Saad Nseir, MD	En recrutement	Contact (sur clinicalTrials)

Critères

Genre

Tous

Nombre d'inclusion

Critère d'inclusion

Inclusion Criteria:

1. Age ≥ 18 y

2. Moderate or severe ARDS (PaO2/FiO2 ≤ 200 mmHg) within 48 h of meeting Berlin ARDS
criteria

Critère de non inclusion

1. Received continuous mechanical ventilation > 7 days

2. Known or clinically suspected elevated intracranial pressure (>18mmHg) necessitating
strict control of PaCO2

3. Known pregnancy

4. Broncho-pleural fistula

5. Severe liver disease (Child-Pugh Score ≥ 10)

6. BMI >40kg/m2

7. Anticipating withdrawal of life support and/or shift to palliation as the goal of
care

8. Patient is receiving ECMO at time of randomization

NCT03963622 - Careful Ventilation in Acute Respiratory Distress Syndrome (CAVIARDS)

Informations générales
Etablissements
Critères
Accès à la fiche NCT

Retour en haut